Groundbreaking genomic test could spare millions of breast cancer patients chemotherapy – The Guardian

  1. Groundbreaking genomic test could spare millions of breast cancer patients chemotherapy  The Guardian
  2. Veracyte genomic test identifies breast cancer patients who can skip chemo  Reuters
  3. Genetic test could offer breast cancer patients chance to skip chemo  The Times
  4. OPTIMA Phase III: Gene Expression Test Helps Identify Patients Who May Avoid Chemotherapy  Docwire News
  5. Breast cancer patients could be spared chemotherapy  The Telegraph

Source: Google Finance – Market News